At least two major states are expected to try to enact new congressional maps — and a looming Supreme Court decision could ...

Relentlessly squeezing out advantages with new maps isn't good for our country, but there is another way, writes the Register ...

The past twelve months were less than kind to Limoneira, which reported a dramatic drop in net revenue for fiscal year 2025.

Little known outside Washington, the deputy chief of staff has emerged as a central power broker shaping loyalty, legislation ...

Editions and drawings are gaining in popularity, particularly with collectors who want to access established and blue-chip names otherwise out of reach.

There are a range of issues facing Louisiana residents as 2025 draws to a close, from skyrocketing insurance costs, stronger ...

Senate President Mary Felzkowski in a year-end interview with the Wisconsin Examiner that the year has been one of “very ...

In Part 2 of his story, Benita Albert tells of astronomer Bob Benjamin's career, including teaching and now being a NASA consultant.

Thank you, Yisca, and thank you all for joining us today. Non-GAAP earnings per share rose 39% year-over-year to $0.28, highlighting the continued scalability and efficiency of our business model.

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...

The precious, fragrant resin is the scent of the festive season and rising in popularity in the wellness industry – but its natural source is being decimated.